The role of cytokines in the initiation and progression of myelofibrosis

HC Hasselbalch - Cytokine & growth factor reviews, 2013 - Elsevier
Myelofibrosis (MF) is a life-threatening blood cancer characterized by progressive bone
marrow fibrosis, splenomegaly, cytopenias, and debilitating constitutional symptoms …

Interferon-alpha and its effects on the cytokine cascade: a pro-and anti-inflammatory cytokine

H Tilg, C Peschel - Leukemia & lymphoma, 1996 - Taylor & Francis
Interferon-alpha (IFNα) has emerged as an important regulator of growth and differentiation,
affecting cellular communication and signal transduction pathways as well as immunological …

[PDF][PDF] Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis

GF Webster, RL Knobler, FD Lublin… - Journal of the …, 1996 - academia.edu
DISCUSSION Miles et al. 8 studied the effect of interferon beta in patients with AIDS-related
Kaposi's sarcoma. They noted ulceration in eight of 39 patients, with more of these adverse …

[HTML][HTML] Interferons and their role in inflammation

H Tilg, A Kaser - Current pharmaceutical design, 1999 - books.google.com
Cytokines are pleiotropic molecules showing a wide variety of biologic functions on various
cells and tissues, and several different cytokines exert similar and overlapping functions on …

[PDF][PDF] Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression?

H Tilg, AR Moschen, A Kaser - European cytokine network, 2009 - Citeseer
Type I interferons (IFNs) are the first line of defence after various infections, and, as
immunomodulatory cytokines, bridge innate and adaptive immunity. IL-17, mainly secreted …

Interleukins: clinical pharmacology and therapeutic use

WE Aulitzky, M Schuler, C Peschel, C Huber - Drugs, 1994 - Springer
With interleukins (IL), a new class of potential drugs has been introduced into clinical
research. These signal peptides are involved in the regulation of many physiological and …

Type I interferons and their therapeutic role in Th2-regulated inflammatory disorders

H Tilg, A Kaser - Expert opinion on biological therapy, 2004 - Taylor & Francis
Cytokines are pleiotropic molecules showing a wide variety of biological functions on
various cells and tissues. Several different cytokines exert similar and overlapping functions …

Induction of interferon regulatory factors, 2′‐5′ oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to …

T Fischer, J Aman, H Van DerKuip… - British journal of …, 1996 - Wiley Online Library
The genes crucially determining the therapeutic response of chronic myelogenous
leukaemia (CML) to interferon‐alpha (IFN‐alpha) are unknown. Recently, two independent …

Recombinant Human Interferon-β-1a (Rebif®) vs Recombinant Interferon-β-1b (Betaseron®) in Healthy Volunteers: A Pharmacodynamic and Tolerability Study

M Buraglio, I Trinchard-Lugan, A Munafo… - Clinical drug …, 1999 - Springer
Objectives: This study compared the pharmacodynamics and tolerability of subcutaneous
6MU (22μg) interferon (IFN)-β-la (Rebif®) and 8MU (250μg) IFN-β-1b (Betaseron®) …

Effects of alpha-interferon on serum beta-2-microglobulin

K Remes, A Tienhaara, TT Pelliniemi - Leukemia & Lymphoma, 1996 - Taylor & Francis
Beta-2-microglobulin (B2M) forms the small invariable light chain subunit of the class I HLA
antigens on the cell membrane of all nucleated cells. During the continuous turnover of the …